Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00590616 · ClinicalTrials.gov registry record

Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study

A clinical trial, sponsored by Creighton University.

Completed
Registry status
125
Enrollment target

NCT00590616 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 125 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00590616 has completed, sponsored by Creighton University.

COMPLETED
Registry status
125 participants
Enrollment target

Study Summary

Aortic atheroma has been correlated with traditional cardiac risk factors, coronary, carotid, renal and peripheral atherosclerosis, and is probably a manifestation of generalized atherosclerosis. Aortic atheroma has also been shown to be associated with atrial fibrillation, aortic valve sclerosis, and other calcification of the fibrous skeleton of the heart. None of the previous studies have looked at the noninvasive prediction of aortic atheroma using the history and physical signs of cardiovascular disease. This would be a time and cost-effective bedside diagnostic tool that would be useful prior to cardiac surgery, cardiac catheterization, and workup of ischemic stroke patients, especially when transesophageal echocardiogram (TEE) is being considered for diagnosis but cannot be obtained due to previously mentioned reasons. Although physical examination of peripheral vascular disease is non-specific, a combination of physical examination signs increases the probability of generalized atherosclerosis.

Interventions

  • PROCEDURE transthoracic examination

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2005-02
Est. Completion 2014-07

Sponsor

Creighton University

98 total trials

What the Registry Record Tells You About NCT00590616

The ClinicalTrials.gov registry entry for NCT00590616 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which transthoracic examination is the first listed.

NCT00590616 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00590616 about?

NCT00590616 is a clinical study titled "Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study". Aortic atheroma has been correlated with traditional cardiac risk factors, coronary, carotid, renal and peripheral atherosclerosis, and is probably a manifestation of generalized atherosclerosis. Aortic atheroma has also been shown to be associated with atrial fibrillation, aortic valve sclerosis, a...

What is the current status of trial NCT00590616?

This trial is currently completed. The enrollment target is 125 participants. The study started on 2005-02. Estimated completion is 2014-07.

What interventions are being tested in trial NCT00590616?

The interventions under investigation include: transthoracic examination (PROCEDURE).

Who is sponsoring clinical trial NCT00590616?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.